A Preview Of Kura Oncology's Earnings
Portfolio Pulse from Benzinga Insights
Kura Oncology (NASDAQ:KURA) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.55. The company's stock performance has been generally negative over the last 52-week period, with shares down 47.68%. Last quarter, the company beat EPS by $0.04, resulting in a 4.36% increase in the share price the next day.
November 01, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kura Oncology is expected to report an EPS of $-0.55 in its upcoming earnings report. The company's stock has been performing negatively, with a 47.68% decrease over the last 52 weeks.
The company's stock has been performing negatively over the past year, which could indicate investor skepticism about its future performance. The upcoming earnings report, particularly if it fails to meet or beat the estimated EPS, could further impact the stock negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100